Genesis Therapeutics is a company that is interested in providing artificial intelligence and bio-technologies in order to discover new medicines. The company was founded in 2019, in San Francisco, California, United States.
The company looks to combine novel deep neural networks, biophysical simulations, and computing infrastructures. The company has an artificial intelligence platform that expands the initial discovery of the PotentialNet and peer-reviewed methods for molecular property predictions. Their methods have been tested against current methods of chemistry.